Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
This slow titration reduces the risk of unpleasant side effects and allows for more control
Novo Nordisks semaglutide franchise alone generated approximately $33 billion in 2025, while Eli Lillys tirzepatide continues to capture significant market share
Opportunity exists for therapies with better tolerability profiles, though it may be difficult for an agent to achieve both enhanced efficacy and tolerability
For patients ready to explore personalized maintenance dosing strategies, Ivms GLP-1 ID program offers the individualized care, ongoing medical support, and comprehensive tools needed to navigate this phase successfully
Compounding practices exist in Canada, but they are primarily governed by provincial regulations to serve the local Canadian population
Endocrine reviews, 34(3), 309338
